

[ Mon, Feb 07th 2022
] - WOPRAI
[ Mon, Feb 07th 2022
] - WOPRAI
[ Mon, Feb 07th 2022
] - WOPRAI
[ Mon, Feb 07th 2022
] - WOPRAI
[ Mon, Feb 07th 2022
] - WOPRAI
[ Mon, Feb 07th 2022
] - WOPRAI
[ Mon, Feb 07th 2022
] - WOPRAI
[ Mon, Feb 07th 2022
] - WOPRAI
[ Mon, Feb 07th 2022
] - WOPRAI
[ Mon, Feb 07th 2022
] - WOPRAI
[ Mon, Feb 07th 2022
] - WOPRAI
[ Mon, Feb 07th 2022
] - WOPRAI
[ Mon, Feb 07th 2022
] - WOPRAI
[ Mon, Feb 07th 2022
] - WOPRAI
[ Mon, Feb 07th 2022
] - WOPRAI
[ Mon, Feb 07th 2022
] - WOPRAI
[ Mon, Feb 07th 2022
] - WOPRAI
[ Mon, Feb 07th 2022
] - WOPRAI
[ Mon, Feb 07th 2022
] - WOPRAI
[ Mon, Feb 07th 2022
] - WOPRAI
[ Mon, Feb 07th 2022
] - WOPRAI
[ Mon, Feb 07th 2022
] - WOPRAI
[ Mon, Feb 07th 2022
] - WOPRAI
[ Mon, Feb 07th 2022
] - WOPRAI
[ Mon, Feb 07th 2022
] - WOPRAI
[ Mon, Feb 07th 2022
] - WOPRAI
[ Mon, Feb 07th 2022
] - WOPRAI
[ Mon, Feb 07th 2022
] - WOPRAI
[ Mon, Feb 07th 2022
] - WOPRAI
Christopher Parkinson Maintained (APD) at Strong Buy with Decreased Target to $312 on, Feb 7th, 2022
Christopher Parkinson of Mizuho, Maintained "Air Products and Chemicals, Inc." (APD) at Strong Buy with Decreased Target from $313 to $312 on, Feb 7th, 2022.
Christopher has made no other calls on APD in the last 4 months.
There are 4 other peers that have a rating on APD. Out of the 4 peers that are also analyzing APD, 2 agree with Christopher's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Josh Silverstein of "Wolfe Research" Downgraded from Buy to Hold and Held Target at $331 on, Thursday, December 9th, 2021
- Stephen Richardson of "Evercore ISI Group" Downgraded from Buy to Hold and Held Target at $330 on, Tuesday, December 7th, 2021
These are the ratings of the 2 analyists that currently disagree with Christopher
- Kevin McCarthy of "Vertical Research" Upgraded from Hold to Strong Buy and Held Target at $335 on, Tuesday, January 4th, 2022
- John McNulty of "BMO Capital" Maintained at Buy with Increased Target to $338 on, Friday, October 15th, 2021
Contributing Sources